Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1961 1
1965 1
1982 1
1989 1
1990 3
1991 4
1992 4
1993 3
1994 7
1995 2
1996 11
1997 12
1998 16
1999 11
2000 9
2001 17
2002 14
2003 16
2004 24
2005 27
2006 28
2007 21
2008 29
2009 27
2010 26
2011 29
2012 34
2013 31
2014 37
2015 44
2016 61
2017 40
2018 37
2019 48
2020 60
2021 91
2022 92
2023 74
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

887 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for cancer ozcan
Search for Caner Özcan instead (2 results)
Principles of adoptive T cell therapy in cancer.
Met Ö, Jensen KM, Chamberlain CA, Donia M, Svane IM. Met Ö, et al. Semin Immunopathol. 2019 Jan;41(1):49-58. doi: 10.1007/s00281-018-0703-z. Epub 2018 Sep 5. Semin Immunopathol. 2019. PMID: 30187086 Review.
Adoptive cell therapy (ACT) utilizing either tumor-infiltrating lymphocyte (TIL)-derived T cells or T cells genetically engineered to express tumor recognizing receptors has emerged as a powerful and potentially curative therapy for several cancers. Many ACT-based therapie …
Adoptive cell therapy (ACT) utilizing either tumor-infiltrating lymphocyte (TIL)-derived T cells or T cells genetically engineered to expres …
Leptomeningeal Metastasis from Non-Small Cell Lung Cancer and Current Landscape of Treatments.
Ozcan G, Singh M, Vredenburgh JJ. Ozcan G, et al. Clin Cancer Res. 2023 Jan 4;29(1):11-29. doi: 10.1158/1078-0432.CCR-22-1585. Clin Cancer Res. 2023. PMID: 35972437 Review.
Leptomeningeal metastasis (LM), also known as leptomeningeal carcinomatosis (LC), is a devastating complication of metastatic cancer that occurs when neoplastic cells invade the meningeal space. ...
Leptomeningeal metastasis (LM), also known as leptomeningeal carcinomatosis (LC), is a devastating complication of metastatic cancer …
Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer.
Ucaryilmaz Metin C, Ozcan G. Ucaryilmaz Metin C, et al. BMC Cancer. 2022 Jun 23;22(1):692. doi: 10.1186/s12885-022-09736-5. BMC Cancer. 2022. PMID: 35739492 Free PMC article.
BACKGROUND: Gastric cancer is one of the deadliest cancers, currently available therapies have limited success. ...We implemented stepwise multivariate Cox regression guided by a pan-cancer analysis in TCGA to identify a poor prognostic gene signature for CAF …
BACKGROUND: Gastric cancer is one of the deadliest cancers, currently available therapies have limited success. ...We implemen …
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine.
Pratz KW, Jonas BA, Pullarkat V, Recher C, Schuh AC, Thirman MJ, Garcia JS, DiNardo CD, Vorobyev V, Fracchiolla NS, Yeh SP, Jang JH, Ozcan M, Yamamoto K, Illes A, Zhou Y, Dail M, Chyla B, Potluri J, Döhner H. Pratz KW, et al. J Clin Oncol. 2022 Mar 10;40(8):855-865. doi: 10.1200/JCO.21.01546. Epub 2021 Dec 15. J Clin Oncol. 2022. PMID: 34910556 Free PMC article. Clinical Trial.
Alternate-day fasting exacerbates doxorubicin cardiotoxicity in cancer chemotherapy.
Pan H, Yang S, Cheng W, Cai Q, Shubhra QTH. Pan H, et al. Trends Endocrinol Metab. 2023 Jul;34(7):392-394. doi: 10.1016/j.tem.2023.05.003. Epub 2023 May 26. Trends Endocrinol Metab. 2023. PMID: 37246117
Despite its efficacy, Dox's clinical application is limited due to its association with significant complications, namely cardiotoxicity and the risk of heart failure. Recent intriguing findings by Ozcan et al. indicate that alternate-day fasting (ADF) significantly exacer …
Despite its efficacy, Dox's clinical application is limited due to its association with significant complications, namely cardiotoxicity and …
Important milestones for cancer at the Nobel prize.
Tanriverdi O, Tasar M, Yilmaz M, Durak MF, Sezer SB, Demir H, Ozcan M. Tanriverdi O, et al. Indian J Cancer. 2020 Oct-Dec;57(4):370-375. doi: 10.4103/ijc.IJC_983_19. Indian J Cancer. 2020. PMID: 33078741 Free article. Review.
We evaluated the history of the Nobel prizes for awards that have been awarded in fields related to cancer. The contents of the research and their contribution to oncology were determined and reviewed. There were nine awards directly related to cancer. Only studies …
We evaluated the history of the Nobel prizes for awards that have been awarded in fields related to cancer. The contents of the resea …
Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170.
Zinzani PL, Thieblemont C, Melnichenko V, Bouabdallah K, Walewski J, Majlis A, Fogliatto L, Garcia-Sancho AM, Christian B, Gulbas Z, Özcan M, Perini GF, Ghesquieres H, Shipp MA, Thompson S, Chakraborty S, Marinello P, Armand P. Zinzani PL, et al. Blood. 2023 Jul 13;142(2):141-145. doi: 10.1182/blood.2022019340. Blood. 2023. PMID: 37130017 Free PMC article. Clinical Trial.
Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
Armand P, Rodig S, Melnichenko V, Thieblemont C, Bouabdallah K, Tumyan G, Özcan M, Portino S, Fogliatto L, Caballero MD, Walewski J, Gulbas Z, Ribrag V, Christian B, Perini GF, Salles G, Svoboda J, Zain J, Patel S, Chen PH, Ligon AH, Ouyang J, Neuberg D, Redd R, Chatterjee A, Balakumaran A, Orlowski R, Shipp M, Zinzani PL. Armand P, et al. J Clin Oncol. 2019 Dec 1;37(34):3291-3299. doi: 10.1200/JCO.19.01389. Epub 2019 Oct 14. J Clin Oncol. 2019. PMID: 31609651 Free PMC article. Clinical Trial.
Advanced MR Techniques for Preoperative Glioma Characterization: Part 2.
Hangel G, Schmitz-Abecassis B, Sollmann N, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A, Ozturk-Isik E, Piskin S, Schmainda KM, Svensson SF, Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T, Hirschler L, Smits M, Petr J, Emblem KE. Hangel G, et al. J Magn Reson Imaging. 2023 Jun;57(6):1676-1695. doi: 10.1002/jmri.28663. Epub 2023 Mar 13. J Magn Reson Imaging. 2023. PMID: 36912262 Free PMC article. Review.
Advanced MR Techniques for Preoperative Glioma Characterization: Part 1.
Hirschler L, Sollmann N, Schmitz-Abecassis B, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, Keil VC, Kim M, Koekkoek JAF, Kukran S, Mancini L, Nechifor RE, Özcan A, Ozturk-Isik E, Piskin S, Schmainda K, Svensson SF, Tseng CH, Unnikrishnan S, Vos F, Warnert E, Zhao MY, Jancalek R, Nunes T, Emblem KE, Smits M, Petr J, Hangel G. Hirschler L, et al. J Magn Reson Imaging. 2023 Jun;57(6):1655-1675. doi: 10.1002/jmri.28662. Epub 2023 Mar 3. J Magn Reson Imaging. 2023. PMID: 36866773 Free PMC article. Review.
887 results